nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Cefepime—Pancytopenia—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Cefepime—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefepime—Neutropenia—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefepime—Sepsis—Epirubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefepime—Anaemia—Irinotecan—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Cefepime—Urticaria—Tamoxifen—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Cefepime—Abdominal pain—Tamoxifen—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Body temperature increased—Erlotinib—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefepime—Abdominal pain—Erlotinib—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefepime—Coma—Doxorubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Cefepime—Anaemia—Gemcitabine—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Cefepime—Leukopenia—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefepime—Pneumonia—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefepime—Paraesthesia—Sunitinib—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefepime—Anaemia—Fluorouracil—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefepime—Dyspnoea—Sunitinib—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Cefepime—Leukopenia—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Cefepime—Renal failure—Docetaxel—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Cefepime—Leukopenia—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Cefepime—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Cefepime—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Pain—Sunitinib—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Constipation—Sunitinib—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Cefepime—Convulsion—Fluorouracil—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Cefepime—Agranulocytosis—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefepime—Confusional state—Irinotecan—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Pruritus—Tamoxifen—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Infection—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Cefepime—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Cefepime—Pruritus—Erlotinib—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Cefepime—Shock—Irinotecan—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Cefepime—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefepime—Haemoglobin—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefepime—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefepime—Haemorrhage—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefepime—Diarrhoea—Tamoxifen—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Infection—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Confusional state—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Abdominal pain—Sunitinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Body temperature increased—Sunitinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Diarrhoea—Erlotinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Cefepime—Infection—Fluorouracil—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Cefepime—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefepime—Dizziness—Tamoxifen—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefepime—Dizziness—Erlotinib—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Cefepime—Erythema multiforme—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Cefepime—Vomiting—Tamoxifen—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefepime—Paraesthesia—Irinotecan—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Hypersensitivity—Sunitinib—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Rash—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Dermatitis—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefepime—Vomiting—Erlotinib—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Dyspnoea—Irinotecan—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Headache—Tamoxifen—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Rash—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefepime—Dermatitis—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefepime—Headache—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefepime—Paraesthesia—Gemcitabine—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefepime—Chills—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefepime—Dyspnoea—Gemcitabine—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefepime—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Cefepime—Paraesthesia—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Pruritus—Sunitinib—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Pain—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Constipation—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Dyspnoea—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Erythema—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Cefepime—Nausea—Tamoxifen—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefepime—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefepime—Constipation—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Pain—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Nausea—Erlotinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Diarrhoea—Sunitinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Dysgeusia—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Feeling abnormal—Irinotecan—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Pain—Fluorouracil—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefepime—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefepime—Dizziness—Sunitinib—pancreatic cancer	0.001	0.001	CcSEcCtD
Cefepime—Feeling abnormal—Gemcitabine—pancreatic cancer	0.001	0.001	CcSEcCtD
Cefepime—Abdominal pain—Irinotecan—pancreatic cancer	0.000988	0.000988	CcSEcCtD
Cefepime—Body temperature increased—Irinotecan—pancreatic cancer	0.000988	0.000988	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000988	0.000988	CcSEcCtD
Cefepime—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000986	0.000986	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—pancreatic cancer	0.000985	0.000985	CcSEcCtD
Cefepime—Anaemia—Docetaxel—pancreatic cancer	0.000978	0.000978	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000967	0.000967	CcSEcCtD
Cefepime—Vomiting—Sunitinib—pancreatic cancer	0.000964	0.000964	CcSEcCtD
Cefepime—Body temperature increased—Gemcitabine—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Cefepime—Rash—Sunitinib—pancreatic cancer	0.000956	0.000956	CcSEcCtD
Cefepime—Dermatitis—Sunitinib—pancreatic cancer	0.000955	0.000955	CcSEcCtD
Cefepime—Urticaria—Fluorouracil—pancreatic cancer	0.000951	0.000951	CcSEcCtD
Cefepime—Headache—Sunitinib—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Cefepime—Leukopenia—Docetaxel—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Cefepime—Body temperature increased—Fluorouracil—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—pancreatic cancer	0.000939	0.000939	CcSEcCtD
Cefepime—Hypersensitivity—Irinotecan—pancreatic cancer	0.000921	0.000921	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—pancreatic cancer	0.000919	0.000919	CcSEcCtD
Cefepime—Convulsion—Docetaxel—pancreatic cancer	0.000917	0.000917	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—pancreatic cancer	0.000912	0.000912	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000906	0.000906	CcSEcCtD
Cefepime—Nausea—Sunitinib—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Cefepime—Renal failure—Epirubicin—pancreatic cancer	0.000898	0.000898	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—pancreatic cancer	0.000888	0.000888	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Cefepime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000882	0.000882	CcSEcCtD
Cefepime—Confusional state—Docetaxel—pancreatic cancer	0.000871	0.000871	CcSEcCtD
Cefepime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000864	0.000864	CcSEcCtD
Cefepime—Pruritus—Gemcitabine—pancreatic cancer	0.000861	0.000861	CcSEcCtD
Cefepime—Infection—Docetaxel—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Cefepime—Diarrhoea—Irinotecan—pancreatic cancer	0.000855	0.000855	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—pancreatic cancer	0.000852	0.000852	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Cefepime—Shock—Docetaxel—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Cefepime—Pruritus—Fluorouracil—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Cefepime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000846	0.000846	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000838	0.000838	CcSEcCtD
Cefepime—Diarrhoea—Gemcitabine—pancreatic cancer	0.000833	0.000833	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Cefepime—Dizziness—Irinotecan—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—pancreatic cancer	0.000824	0.000824	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Cefepime—Diarrhoea—Fluorouracil—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Cefepime—Vomiting—Irinotecan—pancreatic cancer	0.000794	0.000794	CcSEcCtD
Cefepime—Dizziness—Fluorouracil—pancreatic cancer	0.000791	0.000791	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Cefepime—Rash—Irinotecan—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Cefepime—Dermatitis—Irinotecan—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Cefepime—Headache—Irinotecan—pancreatic cancer	0.000783	0.000783	CcSEcCtD
Cefepime—Paraesthesia—Docetaxel—pancreatic cancer	0.000776	0.000776	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—pancreatic cancer	0.000775	0.000775	CcSEcCtD
Cefepime—Vomiting—Gemcitabine—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Cefepime—Dyspnoea—Docetaxel—pancreatic cancer	0.00077	0.00077	CcSEcCtD
Cefepime—Rash—Gemcitabine—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Cefepime—Dermatitis—Gemcitabine—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Cefepime—Headache—Gemcitabine—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Cefepime—Vomiting—Fluorouracil—pancreatic cancer	0.000761	0.000761	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Cefepime—Rash—Fluorouracil—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Cefepime—Dermatitis—Fluorouracil—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Cefepime—Headache—Fluorouracil—pancreatic cancer	0.00075	0.00075	CcSEcCtD
Cefepime—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000746	0.000746	CcSEcCtD
Cefepime—Nausea—Irinotecan—pancreatic cancer	0.000742	0.000742	CcSEcCtD
Cefepime—Pain—Docetaxel—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Cefepime—Constipation—Docetaxel—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Cefepime—Chills—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Cefepime—Nausea—Gemcitabine—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Cefepime—Erythema—Epirubicin—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Cefepime—Feeling abnormal—Docetaxel—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Cefepime—Nausea—Fluorouracil—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Cefepime—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Cefepime—Body temperature increased—Docetaxel—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Cefepime—Abdominal pain—Docetaxel—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Cefepime—Chills—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Cefepime—Erythema—Doxorubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Cefepime—Anaemia—Epirubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Cefepime—Agitation—Epirubicin—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Cefepime—Hypersensitivity—Docetaxel—pancreatic cancer	0.000636	0.000636	CcSEcCtD
Cefepime—Convulsion—Epirubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Cefepime—Pruritus—Docetaxel—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Cefepime—Agitation—Doxorubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Cefepime—Diarrhoea—Docetaxel—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Cefepime—Confusional state—Epirubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000583	0.000583	CcSEcCtD
Cefepime—Infection—Epirubicin—pancreatic cancer	0.000579	0.000579	CcSEcCtD
Cefepime—Shock—Epirubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Cefepime—Dizziness—Docetaxel—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Cefepime—Vomiting—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Cefepime—Rash—Docetaxel—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Cefepime—Dermatitis—Docetaxel—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Cefepime—Headache—Docetaxel—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Cefepime—Infection—Doxorubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Cefepime—Shock—Doxorubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Cefepime—Nausea—Docetaxel—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Cefepime—Constipation—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Cefepime—Pain—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Cefepime—Urticaria—Epirubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Cefepime—Constipation—Doxorubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Cefepime—Pain—Doxorubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000444	0.000444	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000441	0.000441	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Cefepime—Pruritus—Epirubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Cefepime—Dizziness—Epirubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Cefepime—Vomiting—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Cefepime—Rash—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Cefepime—Headache—Epirubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Cefepime—Nausea—Epirubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Cefepime—Rash—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Cefepime—Headache—Doxorubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Cefepime—Nausea—Doxorubicin—pancreatic cancer	0.00032	0.00032	CcSEcCtD
